Amgen Opens Trial In Fight Over Neulasta Generic
Amgen Inc. began its pitch Monday to a Florida federal judge to block Canadian generics maker Apotex Inc. from making a copy of Amgen's blockbuster biologic Neulasta by arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article